KLRB1 and psoriasis: Consistent with our results, studies have also shown a reduction in CD161+ T cells in the inflamed mucosa of ulcerative colitis compared normal control colon [44], and in psoriasis patients persistence of CD161 expression was demonstrated in plaques while lesional T-cell subset were reduced following 16 weeks of therapy [45].